1 of 1
HOUSE DOCKET, NO. 2220 FILED ON: 1/15/2025
HOUSE . . . . . . . . . . . . . . . No. 2502
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
John Francis Moran and Samantha Montaño
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act to clarify prescription monitoring program activities.
_______________
PETITION OF:
NAME:DISTRICT/ADDRESS :DATE ADDED:John Francis Moran9th Suffolk1/15/2025Samantha Montaño15th Suffolk1/17/2025Carmine Lawrence Gentile13th Middlesex1/21/2025Mindy Domb3rd Hampshire2/5/2025 1 of 1
HOUSE DOCKET, NO. 2220 FILED ON: 1/15/2025
HOUSE . . . . . . . . . . . . . . . No. 2502
By Representatives Moran of Boston and Montaño of Boston, a petition (accompanied by bill,
House, No. 2502) of John Francis Moran, Samantha Montaño and others for legislation to clarify
prescription monitoring program activities. Public Health.
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Fourth General Court
(2025-2026)
_______________
An Act to clarify prescription monitoring program activities.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
1 SECTION 1. Section 24A of chapter 94C of the General Laws, as appearing in the 2022
2Official Edition, is hereby amended by inserting after subsection (m) the following subsection:-
3 (n) Notwithstanding subsection (a)(1), the department shall exclude testosterone from the
4list of drugs monitored in the prescription drug monitoring system.
5 SECTION 2. Immediately upon passage of this Act, the department shall delete from the
6prescription monitoring system established under said section 24A any existing data concerning
7the prescribing and dispensing of testosterone.